Abstract
Gene therapy is a promising endeavor for the treatment of disease in the 21st century. The key to capitalize on this venture lies in the availability of efficient gene transfer and expression tools. Viral vectors are useful vehicles for the delivery of foreign genes into target cells, and retroviral vectors have been popular because of their ability to integrate into the host cell genome and maintain persistent gene expression. Recent studies of the human immunodeficiency virus (HIV) have demonstrated that lentiviruses, members of the retroviral family, have the ability to infect cells at both mitotic and post-mitotic stages of the cell cycle. This article aims to analyze the molecular genetics, review existing systems and applications, and address problems as well as potential future developments of the lentiviral vector systems.
Keywords: Molecular Genetics, Lentiviral Vectors, Long Terminal Repeats (LTR), Untranslated Region, Gag-Pol-Env ORFs, Polyadenylation (PolyA), Hematopoietic Precursors, Transgene Expression
Current Gene Therapy
Title: The Molecular Genetics of Lentiviral Vectors - Current and Future Perspectives
Volume: 1 Issue: 3
Author(s): L. J. Chang and E. E. Gay
Affiliation:
Keywords: Molecular Genetics, Lentiviral Vectors, Long Terminal Repeats (LTR), Untranslated Region, Gag-Pol-Env ORFs, Polyadenylation (PolyA), Hematopoietic Precursors, Transgene Expression
Abstract: Gene therapy is a promising endeavor for the treatment of disease in the 21st century. The key to capitalize on this venture lies in the availability of efficient gene transfer and expression tools. Viral vectors are useful vehicles for the delivery of foreign genes into target cells, and retroviral vectors have been popular because of their ability to integrate into the host cell genome and maintain persistent gene expression. Recent studies of the human immunodeficiency virus (HIV) have demonstrated that lentiviruses, members of the retroviral family, have the ability to infect cells at both mitotic and post-mitotic stages of the cell cycle. This article aims to analyze the molecular genetics, review existing systems and applications, and address problems as well as potential future developments of the lentiviral vector systems.
Export Options
About this article
Cite this article as:
Chang J. L. and Gay E. E., The Molecular Genetics of Lentiviral Vectors - Current and Future Perspectives, Current Gene Therapy 2001; 1 (3) . https://dx.doi.org/10.2174/1566523013348634
DOI https://dx.doi.org/10.2174/1566523013348634 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Target Therapies in Pancreatic Carcinoma
Current Medicinal Chemistry HIV and Respiratory Disease: A Contemporary Perspective
Current Respiratory Medicine Reviews Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy
Current Drug Targets Supramolecular Nanomedicine - An Overview
Current Drug Targets Meet Our Editorial Board Member
Recent Patents on Anti-Cancer Drug Discovery Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Current HIV Research Strategies for Effective Naked-DNA Vaccination Against Infectious Diseases
Recent Patents on Anti-Infective Drug Discovery Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cancer Properties
Protein & Peptide Letters Progress Toward Vector Design for Hematopoietic Stem Cell Gene Therapy
Current Gene Therapy Combined Effect of Parthenolide and Various Anti-cancer Drugs or Anticancer Candidate Substances on Malignant Cells in vitro and in vivo
Mini-Reviews in Medicinal Chemistry Primary Tumors of the Sacrum: Imaging Findings
Current Medical Imaging Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Current Pharmaceutical Design Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
Anti-Cancer Agents in Medicinal Chemistry Non-steroidal Anti-Inflammatory Drugs and Melanoma
Current Pharmaceutical Design Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines
Current Cancer Therapy Reviews Inhibitors of Lactate Dehydrogenase Isoforms and their Therapeutic Potentials
Current Medicinal Chemistry Recent Advances in the Therapeutic Perspectives of Nutlin-3
Current Pharmaceutical Design Differential Splicing, Disease and Drug Targets
Infectious Disorders - Drug Targets Population Diversity and its Relationship with Infectious and Tumor Diseases
Current Immunology Reviews (Discontinued) AIDS-Related Kaposis Sarcoma: State of the Art and Therapeutic Strategies
Current HIV Research